GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » Scaled Net Operating Assets

Devyser Diagnostics AB (FRA:OL0) Scaled Net Operating Assets : 0.48 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Devyser Diagnostics AB's operating assets for the quarter that ended in Sep. 2024 was €25.68 Mil. Devyser Diagnostics AB's operating liabilities for the quarter that ended in Sep. 2024 was €4.64 Mil. Devyser Diagnostics AB's Total Assets for the quarter that ended in Jun. 2024 was €43.39 Mil. Therefore, Devyser Diagnostics AB's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.48.


Devyser Diagnostics AB Scaled Net Operating Assets Historical Data

The historical data trend for Devyser Diagnostics AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Scaled Net Operating Assets Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 1.03 0.61 0.69 0.18 0.39

Devyser Diagnostics AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.40 0.44 0.47 0.49

Competitive Comparison of Devyser Diagnostics AB's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Scaled Net Operating Assets falls into.



Devyser Diagnostics AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Devyser Diagnostics AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(22.098-4.489)/45.535
=0.39

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=45.601 - 23.503
=22.098

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=11.175 - 5.122 - 1.564
=4.489

Devyser Diagnostics AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(25.677-4.642)/43.389
=0.48

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=40.774 - 15.097
=25.677

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.033 - 4.184 - 1.207
=4.642

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Devyser Diagnostics AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Devyser Diagnostics AB Business Description

Traded in Other Exchanges
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines